|
Dec 20, 2024
|
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|
|
|
Dec 18, 2024
|
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024
|
|
|
Dec 13, 2024
|
Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement
|
|
|
Dec 04, 2024
|
Zimmer Biomet Receives FDA Clearance for Persona® SoluTion™ PPS® Femur
|
|
|
Nov 25, 2024
|
Zimmer Biomet Receives FDA Approval for Oxford® Cementless Partial Knee, Only Cementless Partial Knee Replacement Implant in the U.S.
|
|
|
Nov 21, 2024
|
Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference
|
|
|
Nov 18, 2024
|
Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System
|
|
|
Nov 13, 2024
|
Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer
|
|
|
Nov 07, 2024
|
Zimmer Biomet to Present at Jefferies London Healthcare Conference
|
|
|
Oct 30, 2024
|
Zimmer Biomet Announces Third Quarter 2024 Financial Results
|
|